Interesting facts
              Interesting Facts about 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-fluoro-pyrimidine-2,4-dione
This compound represents a fascinating intersection of organic chemistry and pharmaceutical applications, making it a notable subject of study for many researchers. Here are some intriguing aspects:
- Structure Complexity: The compound features a unique structural arrangement, including both a pyrimidine and a tetrahydrofuran ring, contributing to its biological activity.
- Fluorine Substitution: The presence of fluorine in the pyrimidine ring often enhances the compound's stability and lipophilicity, which can improve its absorption and efficacy as a drug.
- Hydroxyl Groups: The multiple hydroxyl (-OH) groups in the tetrahydrofuran moiety play a critical role in determining the compound's solubility and reactivity, potentially facilitating hydrogen bonding with biological targets.
- Potential Applications: Given its structure, this compound could serve as a lead compound in the development of antiviral or anticancer agents. The ability of pyrimidine derivatives to interfere with nucleic acid synthesis positions them as valuable in medical research.
- Chirality Matters: The chirality of the tetrahydrofuran component suggests that different enantiomers could exhibit distinct biological behaviors, making stereochemical purity vital in pharmaceutical development.
As noted in a scientific paper, "Understanding the synthetic pathways and biological interactions of such complex compounds can unlock new therapeutic strategies." This underscores the importance of this compound in ongoing research and its potential to contribute to medical advancements in the near future.
Overall, studying this compound opens a window into the intricate world of organic chemistry and its significant impact on drug discovery.
Synonyms
          5-Fluorouridine
          316-46-1
          5-Fur
          Uridine, 5-fluoro-
          fluorouridine
          5-Fluoro Uridine
          1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-fluoropyrimidine-2,4(1H,3H)-dione
          5-Fluoro-uridine
          5-Fluorouracil 1beta-D-ribofuranoside
          EINECS 206-260-3
          MFCD00036832
          NSC 146604
          BRN 0033662
          FUrd
          CHEBI:40154
          UNII-4K0M952561
          1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-fluoropyrimidine-2,4-dione
          5-fluoro-1-(beta-d-ribofuranosyl)uracil
          CHEMBL54918
          4K0M952561
          DTXSID4040397
          4-24-00-01231 (Beilstein Handbook Reference)
          NSC-146604
          1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-fluoro-1,2,3,4-tetrahydropyrimidine-2,4-dione
          5-FLUOROURACIL-.BETA.-D-RIBOFURANOSIDE
          5-FLUOROURACIL-1.BETA.-D-RIBOFURANOSIDE
          Fur
          C9H11FN2O6
          1-(b-D-Xylofuranosyl)-5-fluorouracil
          1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-5-fluoro-1,2,3,4-tetrahydropyrimidine-2,4-dione
          1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-5-fluoropyrimidine-2,4-dione
          5UD
          5-fluoro-d-uridine
          beta-D-5FdU
          5-fluorouracil-1beta-d-ribofuranoside
          4pb2
          cid_1821
          SCHEMBL53091
          BIDD:GT0496
          GTPL4614
          DTXCID2020397
          18814-21-6
          AFU
          BDBM50132299
          AKOS015852922
          AKOS015918304
          5-Fluorouracil 1-.beta.-D-arabinosyl
          DB01629
          NF04076
          5-Fluorouridine, >=99.0% (HPLC)
          NCGC00142485-01
          NCGC00142485-02
          NCGC00142485-03
          1-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-fluoro-1,3-dihy dropyrimidine-2,4-dione
          5-Fluoro-1-.beta.-D-ribofuranosyluracil
          AS-13467
          BP-58617
          PD008907
          5-FLUOROURACIL-BETA-D-RIBOFURANOSIDE
          DB-005381
          HY-107856
          CS-0030739
          NS00015326
          EN300-221740
          F58596
          Q27073979
          Z1741958657
          1-(b-D-Ribofuranosyl)-5-fluorouracil;5-Fluoro-D-uridine;FUrd
          1-.beta.-D-Arabinofuranosyl-5-fluoro-(1H,3H)-pyrimidine-2,4-dione
          2,4(1H,3H)-Pyrimidinedione, 1-.beta.-D-arabinofuranosyl-5-fluoro-
          5-Fluorouridine, proapoptotic anitproliferative plant growth regulator
          1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-fluoro-1H-pyrimidine-2,4-dione
          1-((2R,5R)-3,4-Dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-fluoro-1H-pyrimidine-2,4-dione
          1-(3,4-Dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-fluoro-1H-pyrimidine-2,4-dione(5F-dUrd)
          1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-fluoro-pyrimidine-2,4-dione
          206-260-3
              
Solubility of 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-fluoro-pyrimidine-2,4-dione
The solubility of 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-fluoro-pyrimidine-2,4-dione is influenced by multiple factors, considering the complexity of its structure. This compound contains functional groups that can significantly affect its interaction with solvents:
It is essential to note that solubility might be relatively high in water due to hydrophilic interactions caused by the hydroxyl groups, yet the fluorine can potentially introduce some hydrophobic characteristics that counteract total solubility. In summary, it can be expressed as:
Experimental data would ultimately be required for precise solubility values, but the theoretical understanding suggests this compound might showcase variability in solubility across different solvents, illustrating the fascinating nature of organic compounds.